関連する実験動画
Updated: Feb 22, 2026
04:39
Generation of a Mouse Spontaneous Autoimmune Thyroiditis Model
Published on: March 17, 2023
2.6K
炎症性腸疾患は,自己免疫性甲状腺炎のリスクの増加と関連していません
Alexander Barton1, Christian Labenz2,3, Stephan Grabbe4
1Department of Medicine II, Saarland University Medical Center, Saarland University, 66421 Homburg, Germany.
Medical sciences (Basel, Switzerland)
|February 20, 2026
まとめ
炎症性腸疾患 (IBD) は全体的に自己免疫性甲状腺炎と関連していません. しかし,IBDの高齢者 (≥65) は,グラブス病のリスクが高く,年齢別モニタリングが重視されています.
科学分野:
- 胃腸内科 胃腸内科
- エンドクリノロジー エンドクリノロジー
- エピデミオロジー エピデミオロジー
背景:
- 炎症性腸疾患 (IBD) の世界的な発生率は上昇しており,北米とヨーロッパで最も高い罹患率を示しています.
- IBDと自己免疫性甲状腺炎の発症との関連に関する証拠は限られている.
- この研究は,IBDと自己免疫性甲状腺炎の関連性を,ドイツの大規模なコホートで取り上げています.
研究 の 目的:
- IBDとその後の自己免疫性甲状腺炎の関連性を調査する.
- IBD患者におけるハシモト症の甲状腺炎とグレイヴス病のリスクを分析する.
- IBDと自己免疫性甲状腺炎の間の年齢特有の関連性を評価する.
主な方法:
- 20,084人のIBD患者と100,420人の対照群の傾向スコアマッチング.
- クローン病と潰瘍性大腸炎の患者を含む.
- 10年間のコックス回帰を用いた自己免疫性甲状腺炎の発生率の評価.
主要な成果:
- IBDと自己免疫性甲状腺炎の間の有意な全体的な関連性は見つかりませんでした.
- IBDとグレイヴス病の間の有意な関連性は,65歳以上の患者で観察されました.
- 高齢者のグレイブス病のリスクの増加は,クローン病と潰瘍性大腸炎の両方で見られました.
結論:
- IBDは一般的に自己免疫性甲状腺炎と関連していません.
- IBDとGraves病の間で顕著な正の関連性が65歳以上の個人に存在する.
- 年齢特有のリスク評価は,甲状腺自身免疫に関するIBD患者の管理に不可欠です.
キーワード:
グレイヴズ病 (Graves disease) とは,グレイヴス病 (Graves disease) とは,グレイヴス病 (Graves disease) とは,グレイヴス病 (Graves disease) とは,グレイヴス病 (Graves disease) とは,グレイヴス病 (Graves disease) とは,グレイヴス病 (Graves disease) とは,グレイヴス病 (Graves disease) とは,グレイヴス病 (Graves disease) とは,グレイヴス病 (Graves disease) とは,グレイヴス病 (Graves disease) とは,自己免疫性甲状腺炎は,自己免疫性甲状腺炎である.コホート研究はコホート研究です.炎症性腸疾患とは
関連する概念動画
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
1.2K
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
1.2K
01:29Autoimmune Disorders
2.0K
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
Concept and Mechanism of Autoimmune Diseases
The immune...
2.0K
01:17Chronic Bowel Disorders: Introduction
829
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
829
01:30Inflammatory Bowel Disease II: Crohn's Disease
1.3K
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
1.3K
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
950
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
950
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
610
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
610